Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery

References

Page 1

	Year	Citations
Recommended standards for reports dealing with lower extremity ischemia: Revised version Robert B. Rutherford, J.Dennis Baker, Calvin B. Ernst, Journal of Vascular Surgery Ischemic StrokeMedicinePatient SafetyLower Extremity WoundVascular Surgery	1997	3.5K
Efficacy and Safety of Edifoligide, an E2F Transcription Factor Decoy, for Prevention of Vein Graft Failure Following Coronary Artery Bypass Graft Surgery JAMA	2005	657
A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Ryuichi Morishita, Gary H. Gibbons, Masatsugu Horiuchi, Proceedings of the National Academy of Sciences ImmunologyDna TechnologyTranscription Factor DecoyTranscriptional RegulationAngiogenesis	1995	482
Present status of reversed vein bypass grafting: Five-year results of a modern series Lloyd M. Taylor, James M. Edwards, John M. Porter Journal of Vascular Surgery Present StatusVenous DiseaseEndovascular TechniqueVascular SurgeryModern Series	1990	449
Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial Michael J. Mann, Anthony D. Whittemore, Magruder C. Donaldson, The Lancet Translational MedicineGene TherapiesTransplantationCell TherapyIn Vivo Gene Therapy	1999	400
Regulation of Gene Expression with Double-Stranded Phosphorothioate Oligonucleotides Anna U. Bielinska, Ramesh A. Shivdasani, Liquan Zhang, Science	1990	372
Cell Cycle Progression Ruediger C. Braun‐Dullaeus, Michael J. Mann, Victor J. Dzau Circulation	1998	286
Developing the Vascular Quality of Life Questionnaire: A new disease-specific quality of life measure for use in lower limb ischemia M. Morgan, Tim Crayford, Ben Murrin, Journal of Vascular Surgery Quality Of LifeLife AssessmentHealth PolicyCardiovascular DiseaseLower Limb Ischemia	2001	272
Risk factors, medical therapies and perioperative events in limb salvage surgery: Observations from the PREVENT III multicenter trial Michael S. Conte, Dennis F. Bandyk, Alexander W. Clowes, Journal of Vascular Surgery Limb ReconstructionMedicinePatient SafetyPerioperative SafetyPostoperative Consideration	2005	154
Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy Afshin Ehsan, Michael J. Mann, Giorgio Dell’Acqua, Journal of Thoracic and Cardiovascular Surgery ThrombosisVascular DiseaseLong-term StabilizationIn Vivo Gene TherapyCardiovascular Disease	2001	135

Page 1